Subsequent to the end of the third quarter of 2024, the Company closed its previously announced registered direct offering ... of Valley Veterinary animal hospital in the fourth quarter of 2023.
Furthermore, it is noted that Innocan has made strong progress with the FDA's Center for Veterinary Medicine (CVM) with the issuance of an Investigational New Animal Drug (INAD) designation in July.